Andrew Lawrence Taylor, Chief Financial Officer at Orchestra BioMed Holdings, Inc. (OBIO), bought 1,000 shares at $4.83 ($5K) on 2024-12-19, disclosed to the SEC on 2024-12-20.
Open-market purchase of $5k OBIO by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| MOTS | BUY | 2020-12-10 | $1K | — | Filing → |
| MOTS | BUY | 2018-12-26 | $3K | — | Filing → |
| MOTS | BUY | 2018-02-21 | $10K | — | Filing → |